Tag #Hims

Showing 1 to 3 of 3 results

forbes.com
🌐 75% Global Worthiness
News related image

HIMS Earnings Announcement: 47% Chance of Positive One-Day Return

Hims & Hers Health (HIMS) reports earnings on August 4, 2025; historical data shows a 47% chance of positive one-day returns post-earnings, with analysts projecting substantial revenue growth compared to last year.

Progress

36% Bias Score

Decent Work and Economic Growth
cnbc.com
🌐 65% Global Worthiness
News related image

HIMS Stock Rises Despite Volatility, Driven by Diverse Revenue Streams

Hims & Hers Health (HIMS) stock price rose from $23.50 in July to $32.50 currently, despite September's dip below $14; its compounded semaglutide injections, representing under 10% of revenue, contribute to volatility, while the company shows continued strength.

Progress

40% Bias Score

Good Health and Well-being
dailymail.co.uk
🌐 85% Global Worthiness
News related image

FDA Warns of Serious Side Effects from Online Topical Finasteride

The FDA warned about serious side effects, including sexual dysfunction and suicidal ideation, from unapproved topical finasteride hair-loss treatments sold online by telehealth companies like Hims, Hers, and Ro, with 32 complaints filed between 2019 and 2024.

Progress

64% Bias Score

Good Health and Well-being

Showing 1 to 3 of 3 results